Cargando…
How Are New Vaccines Prioritized in Low-Income Countries? A Case Study of Human Papilloma Virus Vaccine and Pneumococcal Conjugate Vaccine in Uganda
Background: To date, research on priority-setting for new vaccines has not adequately explored the influence of the global, national and sub-national levels of decision-making or contextual issues such as political pressure and stakeholder influence and power. Using Kapiriri and Martin’s conceptual...
Autores principales: | Wallace, Lauren, Kapirir, Lydia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kerman University of Medical Sciences
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726321/ https://www.ncbi.nlm.nih.gov/pubmed/29172378 http://dx.doi.org/10.15171/ijhpm.2017.37 |
Ejemplares similares
-
Pneumococcal conjugate vaccine implementation in middle-income countries
por: Tricarico, Serena, et al.
Publicado: (2017) -
Effect of Pneumococcal Conjugate Vaccination in Uruguay, a Middle-Income Country
por: García Gabarrot, Gabriela, et al.
Publicado: (2014) -
Surveillance of the impact of pneumococcal conjugate vaccines in developing countries
por: Rodgers, Gail L, et al.
Publicado: (2015) -
Impact of Pneumococcal Conjugate Vaccines on Pneumonia Hospitalizations in High- and Low-Income Subpopulations in Brazil
por: Warren, Joshua L, et al.
Publicado: (2017) -
Pneumococcal Carriage in Children under Five Years in Uganda-Will Present Pneumococcal Conjugate Vaccines Be Appropriate?
por: Lindstrand, Ann, et al.
Publicado: (2016)